Search Within

Sujata Patil

  1. "Molecular Imaging and Therapy Service"
Formats
  1. Journal Article (17)
  2. Meeting Abstract (13)
Groups
  1. Biostatistics Service (30)
  2. Epidemiology and Biostatistics (30)
  3. Molecular Imaging and Therapy Service (30)
  4. Radiology, Department of (29)
  5. Department of Medicine (24)
  6. Solid Tumor Oncology Division (24)

More Groups

People
  1. Clifford Hudis (12)
  2. Maxine Jochelson (12)
  3. Komal Jhaveri (10)
  4. Steven Larson (9)
  5. Shanu Modi (8)
  6. Heather Mcarthur (7)

More People

Years
  1. 2024 (1)
  2. 2022 (1)
  3. 2021 (1)
  4. 2020 (3)
  5. 2019 (6)
  6. 2017 (3)

More Years

Publications
  1. Journal of Clinical Oncology (9)
  2. Cancer Research (3)
  3. Annals of Surgical Oncology (2)
  4. BMC Urology (1)
  5. Breast Cancer Research and Treatment (1)
  6. Cancer (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (10)
  2. American Association for Cancer Research (4)
  3. Springer (3)
  4. Elsevier Inc. (2)
  5. Nature Publishing Group (2)
  6. Oxford University Press (2)

More Publishers

Results (30)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Tumor epichaperome expression using (124)I PU-H71 PET (PU-PET) as a biomarker of response for PU-H71 plus nab-paclitaxel in HER2 negative (HER2-) metastatic breast cancer (MBC)
    Meeting Abstract

    Jhaveri, K.; Dunphy, M.; Wang, R.; Comen, E.; Fornier, M.; Moynahan, M. E.; Bromberg, J.; Ma, W.; Patil, S.; Taldone, T.; more...
    Cancer Research (2019)

    Fulltext@MSK | Save
  • Phase II study of weekly paclitaxel with trastuzumab and pertuzumab in patients with human epidermal growth receptor 2 overexpressing metastatic breast cancer: 5-year follow-up
    Journal Article

    Wang, R.; Smyth, L. M.; Iyengar, N.; Chandarlapaty, S.; Modi, S.; Jochelson, M.; Patil, S.; Norton, L.; Hudis, C. A.; Dang, C. T.
    The Oncologist (2019)

    Fulltext@MSK | Save
  • Preliminary results from a single-arm, phase II study assessing the efficacy of pembrolizumab plus radiotherapy in metastatic triple negative breast cancer
    Meeting Abstract

    Ho, A.; Barker, C. A.; Gucalp, A.; Lebron-Zapata, L.; Wen, Y. H.; Phung, A.; Wilgucki, M.; Henrich, M.; Arnold, B.; Patil, S.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Quantifying the incidence of homologous recombination repair status in metastatic triple negative breast cancer receiving concurrent cisplatin and radiation therapy
    Meeting Abstract

    Powell, S. N.; Gucalp, A.; Traina, T. A.; Patil, S.; Wilgucki, M.; Arnold, B. B.; Cahlon, O.; Delsite, R.; Ulaner, G. A.; Ho, A. Y.
    International Journal of Radiation Oncology, Biology, Physics (2017)

    Fulltext@MSK | Save
  • Do calcifications seen on mammography after neoadjuvant chemotherapy for breast cancer always need to be excised?
    Journal Article

    Feliciano, Y.; Mamtani, A.; Morrow, M.; Stempel, M. M.; Patil, S.; Jochelson, M. S.
    Annals of Surgical Oncology (2017)

    Fulltext@MSK | Save
  • The epichaperome is an integrated chaperome network that facilitates tumour survival
    Journal Article

    Rodina, A.; Wang, T.; Yan, P.; Gomes, E. D.; Dunphy, M. P. S.; Pillarsetty, N.; Koren, J. 3rd; Gerecitano, J. F.; Taldone, T.; Zong, H.; more...
    Nature (2016)

    Fulltext@MSK | Save
  • Is preoperative axillary imaging beneficial in identifying clinically node-negative patients requiring axillary lymph node dissection?
    Journal Article

    Pilewskie, M.; Jochelson, M.; Gooch, J. C.; Patil, S.; Stempel, M.; Morrow, M.
    Journal of the American College of Surgeons (2016)

    Fulltext@MSK | Save
  • Is preoperative axillary imaging beneficial in identifying clinically node-negative patients requiring axillary lymph node dissection?
    Meeting Abstract

    Pilewskie, M.; Jochelson, M.; Gooch, J.; Patil, S.; Stempel, M.; Morrow, M.
    Annals of Surgical Oncology (2015)

    Fulltext@MSK | Save
  • Phase II study of paclitaxel given once per week along with trastuzumab and pertuzumab in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer
    Journal Article

    Dang, C.; Iyengar, N.; Datko, F.; D'Andrea, G.; Theodoulou, M.; Dickler, M.; Goldfarb, S.; Lake, D.; Fasano, J.; Fornier, M.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • A phase I trial of sorafenib with whole brain radiotherapy (WBRT) in breast cancer patients with brain metastases and a correlative study of FLT-PET brain imaging to evaluate treatment response after WBRT sorafenib
    Meeting Abstract

    Morikawa, A.; Jhaveri, K. L.; Patil, S.; Chen, M.; Mcdonnell, E.; Neville, D. A.; Mak, F. M.; Gansukh, B.; Humm, J. L.; Holodny, A.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save